Interim results to 31 March 2014

IXICO today announces its unaudited interim results for the six months ended 31 March 2014.


  • Successful launch of Assessa®, our CE-marked digital healthcare platform for decision-support in dementia diagnosis
  • Expansion in clinical trials and experimental medicine business
  • Continuing business development in China
  • Financial performance on budget and in-line with expectations
By |2017-10-11T11:47:13+00:006 June 2014|Financial|